Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Baldo

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Children (Basel, Switzerland)|May 25, 2024
Pre-Rheumatology Referral Consultation and Investigation Pattern in Children with Joint Complaints: Focus on Juvenile Idiopathic ArthritisAchille Marino, Paola Baldassarre, Cristina Ferrigno, et al.
Arthritis Research & Therapy|January 8, 2026
Development of a scoring system to assist clinicians in the early referral of patients with suspected juvenile idiopathic arthritis: the EasyJIA scoreAchille Marino, Carlo Alberto Scirè, Paola Baldassarre, et al.
Paediatric Drugs|June 14, 2020
Selumetinib in the Treatment of Symptomatic Intractable Plexiform Neurofibromas in Neurofibromatosis Type 1: A Prospective Case Series with Emphasis on Side EffectsFrancesco Baldo, Antonio Giacomo Grasso, Luisa Cortellazzo Wiel, et al.
Children (Basel, Switzerland)|April 23, 2022
Infection-Triggered Hyperinflammatory Syndromes in ChildrenMartina Rossano, Greta Rogani, Maria Maddalena D'Errico, et al.
Therapeutic Advances in Musculoskeletal Disease|April 3, 2026
Safety of intravenous neridronate in pediatric patients: insights from the monocentric retrospective NAPOLEON cohortStefania Costi, Andrea Amati, Raffaele Di Taranto, et al.
Seminars in Arthritis and Rheumatism|June 25, 2025
The effectiveness and safety of rituximab in juvenile idiopathic arthritis: Hints from the ITHACA monocentric registryMaria Rosa Pellico, Marco Pandolfi, Andrea Amati, et al.
BMC Pediatrics|June 9, 2026
Selumetinib in the treatment of plexiform neurofibromas in neurofibromatosis type 1: a 6-year prospective case series with review of the literatureFrancesco Baldo, Luca Messana, Alberto Andresani, et al.
Therapeutic Advances in Musculoskeletal Disease|May 15, 2026
Effectiveness and safety of neridronate in chronic nonbacterial osteomyelitis: insight from the CAMELOT registryAchille Marino, Andrea Amati, Raffaele Di Taranto, et al.
International Journal of Molecular Sciences|May 7, 2025
Uncovering a Novel Pathogenic Mechanism of <i>BCS1L</i> in Mitochondrial Disorders: Insights from Functional Studies on the c.38A>G VariantValeria Capaci, Luisa Zupin, Martina Magistrati, et al.
Expert Opinion on Biological Therapy|June 28, 2026
TNF inhibitors for the long-term management of juvenile idiopathic arthritis associated uveitis: real-life data from the ITHACA cohortAchille Marino, Dariush Khaleghi Hashemian, Claudia Iannone, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Children (Basel, Switzerland)|May 25, 2024
Pre-Rheumatology Referral Consultation and Investigation Pattern in Children with Joint Complaints: Focus on Juvenile Idiopathic ArthritisAchille Marino, Paola Baldassarre, Cristina Ferrigno, et al.
Arthritis Research & Therapy|January 8, 2026
Development of a scoring system to assist clinicians in the early referral of patients with suspected juvenile idiopathic arthritis: the EasyJIA scoreAchille Marino, Carlo Alberto Scirè, Paola Baldassarre, et al.
Paediatric Drugs|June 14, 2020
Selumetinib in the Treatment of Symptomatic Intractable Plexiform Neurofibromas in Neurofibromatosis Type 1: A Prospective Case Series with Emphasis on Side EffectsFrancesco Baldo, Antonio Giacomo Grasso, Luisa Cortellazzo Wiel, et al.
Children (Basel, Switzerland)|April 23, 2022
Infection-Triggered Hyperinflammatory Syndromes in ChildrenMartina Rossano, Greta Rogani, Maria Maddalena D'Errico, et al.
Therapeutic Advances in Musculoskeletal Disease|April 3, 2026
Safety of intravenous neridronate in pediatric patients: insights from the monocentric retrospective NAPOLEON cohortStefania Costi, Andrea Amati, Raffaele Di Taranto, et al.
Seminars in Arthritis and Rheumatism|June 25, 2025
The effectiveness and safety of rituximab in juvenile idiopathic arthritis: Hints from the ITHACA monocentric registryMaria Rosa Pellico, Marco Pandolfi, Andrea Amati, et al.
BMC Pediatrics|June 9, 2026
Selumetinib in the treatment of plexiform neurofibromas in neurofibromatosis type 1: a 6-year prospective case series with review of the literatureFrancesco Baldo, Luca Messana, Alberto Andresani, et al.
Therapeutic Advances in Musculoskeletal Disease|May 15, 2026
Effectiveness and safety of neridronate in chronic nonbacterial osteomyelitis: insight from the CAMELOT registryAchille Marino, Andrea Amati, Raffaele Di Taranto, et al.
International Journal of Molecular Sciences|May 7, 2025
Uncovering a Novel Pathogenic Mechanism of <i>BCS1L</i> in Mitochondrial Disorders: Insights from Functional Studies on the c.38A>G VariantValeria Capaci, Luisa Zupin, Martina Magistrati, et al.
Expert Opinion on Biological Therapy|June 28, 2026
TNF inhibitors for the long-term management of juvenile idiopathic arthritis associated uveitis: real-life data from the ITHACA cohortAchille Marino, Dariush Khaleghi Hashemian, Claudia Iannone, et al.
Pageof 5